ESO Lymphoma Course
Avatar

Efficacy and Safety of Anti-CD19 CAR T-cell Therapy in B-cell Lymphoma, Update on ZUMA - 1 Trial & Strategies for Improving Efficacy of CAR T Therapy

By ESO Lymphoma Course FEATURING Sattva Neelapu
By ESO Lymphoma Course FEATURING Sattva Neelapu
115 views
September 3, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
13:07
Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin
10:04
Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

20:18
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale
08:23
Total Health

R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment

Feat. J. Chandler, B. Randolph, M. Onciu
08:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Speci…

Feat. R. Bansal
04:08
GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman
62:02
UChicago Medicine

New Treatment Strategies in DLBCL

Feat. L. Sehn
09:45
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …

Feat. M. Kamdar
16:03
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New Algorithm for 2L LBCL

Feat. J. Westin
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June
15:26
Moffitt Cancer Center

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Feat. A. Lazaryan
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
25:44
Tara Graff

DLBCL Updates From iCML 2023

07:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…

Feat. L. Shune
35:28
UNC Lineberger Comprehensive Cancer Center

DLBCL Management: Updates for 2023

Feat. N. Grover
25:24
Beth Israel Deaconess Medical Center

CAR T-Cell Failure: Mechanisms and Salvage Options

Feat. J. Arnason
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
39:39
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

R/R DLBCL Updates: Will Bispecific Antibodies Compete With CAR T-Cel…

Feat. J. Abramson
11:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Selection of Bispecific Antibody Therapies …

Feat. M. Kamdar